Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jonathan A. Fletcher, M.D.

Co-Author

This page shows the publications co-authored by Jonathan Fletcher and Antonio Perez-Atayde.
Connection Strength

1.629
  1. Hemangiopericytoma of the tongue in a 12-year-old child: ultrastructural and cytogenetic observations. Hum Pathol. 1994 Apr; 25(4):425-9.
    View in: PubMed
    Score: 0.148
  2. Strong expression of IGF1R in pediatric gastrointestinal stromal tumors without IGF1R genomic amplification. Int J Cancer. 2010 Dec 01; 127(11):2718-22.
    View in: PubMed
    Score: 0.117
  3. Osteofibrous dysplasia and adamantinoma in children and adolescents: a clinicopathologic reappraisal. Am J Surg Pathol. 2008 Mar; 32(3):363-76.
    View in: PubMed
    Score: 0.097
  4. Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors. Cancer Res. 2007 Oct 01; 67(19):9084-8.
    View in: PubMed
    Score: 0.094
  5. Cytogenetic and p53 profiles in congenital cystic adenomatoid malformation: insights into its relationship with pleuropulmonary blastoma. Pediatr Dev Pathol. 2006 May-Jun; 9(3):190-5.
    View in: PubMed
    Score: 0.085
  6. Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes. Oncogene. 2005 May 12; 24(21):3419-26.
    View in: PubMed
    Score: 0.080
  7. USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts. Am J Pathol. 2004 Nov; 165(5):1773-80.
    View in: PubMed
    Score: 0.077
  8. Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol. 2004 Oct 15; 22(20):4135-9.
    View in: PubMed
    Score: 0.077
  9. USP6 (Tre2) fusion oncogenes in aneurysmal bone cyst. Cancer Res. 2004 Mar 15; 64(6):1920-3.
    View in: PubMed
    Score: 0.074
  10. BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res. 2003 Jan 15; 63(2):304-7.
    View in: PubMed
    Score: 0.068
  11. BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19). Am J Pathol. 2001 Dec; 159(6):1987-92.
    View in: PubMed
    Score: 0.063
  12. Gains of chromosome 8 are confined to mesenchymal components in pleuropulmonary blastoma. Pediatr Dev Pathol. 2001 Sep-Oct; 4(5):434-45.
    View in: PubMed
    Score: 0.062
  13. Upper respiratory tract carcinoma with chromosomal translocation 15;19: evidence for a distinct disease entity of young patients with a rapidly fatal course. Cancer. 2001 Sep 01; 92(5):1195-203.
    View in: PubMed
    Score: 0.062
  14. Re: O'Sullivan MJ, Kyriakos M, Zhu X, Wick MR, Swanson PE, Dehner LP, Humphrey PA, Pfeifer JD: malignant peripheral nerve sheath tumors with t(X;18). A pathologic and molecular genetic study. Mod pathol 2000;13:1336-46. Mod Pathol. 2001 Jul; 14(7):733-7.
    View in: PubMed
    Score: 0.061
  15. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am J Pathol. 2000 Aug; 157(2):377-84.
    View in: PubMed
    Score: 0.057
  16. Renal cell carcinomas in children and young adults: increased incidence of papillary architecture and unique subtypes. Am J Surg Pathol. 1999 Jul; 23(7):795-802.
    View in: PubMed
    Score: 0.053
  17. Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. Am J Pathol. 1998 Nov; 153(5):1451-8.
    View in: PubMed
    Score: 0.051
  18. Frequency and implications of chromosome 8 and 12 gains in Ewing sarcoma. Cancer Genet Cytogenet. 1998 Jan 15; 100(2):106-10.
    View in: PubMed
    Score: 0.048
  19. ALK-rearranged renal cell carcinomas in children. Genes Chromosomes Cancer. 2016 May; 55(5):442-51.
    View in: PubMed
    Score: 0.042
  20. Congenital "neurovascular hamartoma" of the skin. A possible marker of malignant rhabdoid tumor. Am J Surg Pathol. 1994 Oct; 18(10):1030-8.
    View in: PubMed
    Score: 0.038
  21. Aberrant AKT activation drives well-differentiated liposarcoma. Proc Natl Acad Sci U S A. 2011 Sep 27; 108(39):16386-91.
    View in: PubMed
    Score: 0.031
  22. Ovarian granulosa-stromal cell tumors are characterized by trisomy 12. Am J Pathol. 1991 Mar; 138(3):515-20.
    View in: PubMed
    Score: 0.030
  23. Cytogenetic aberrations in perineurioma: variation with subtype. Am J Surg Pathol. 2005 Sep; 29(9):1164-9.
    View in: PubMed
    Score: 0.020
  24. Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7;12). Am J Pathol. 2004 May; 164(5):1645-53.
    View in: PubMed
    Score: 0.019
  25. The role of chromosomal translocation (15;19) in the carcinoma of the upper aerodigestive tract in children. Otolaryngol Head Neck Surg. 2003 Dec; 129(6):698-704.
    View in: PubMed
    Score: 0.018
  26. Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation. Proc Natl Acad Sci U S A. 2003 May 13; 100(10):6051-6.
    View in: PubMed
    Score: 0.017
  27. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol. 2001 Jul; 159(1):179-92.
    View in: PubMed
    Score: 0.015
  28. Cystic neuroblastoma: emphasis on gene expression, morphology, and pathogenesis. Pediatr Dev Pathol. 1998 Jan-Feb; 1(1):17-28.
    View in: PubMed
    Score: 0.012
  29. Cytology of typical and atypical Ewing's sarcoma/PNET. Am J Clin Pathol. 1996 Nov; 106(5):620-4.
    View in: PubMed
    Score: 0.011
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.